The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
Abstract
OBJECTIVE: Nephrogenic systemic fibrosis (NSF) is a rare multisystemic fibrosing disorder that principally affects the skin but may affect other organs of patients with renal insufficiency. The purpose of our study was to identify any common risk factors and determine whether i.v. gadodiamide is associated with the development of NSF. MATERIALS AND METHODS: A retrospective chart review was performed for all 12 patients diagnosed with NSF at our institution between 2000 and 2006 to identify the clinical manifestations, timing, and dose of gadodiamide administration; dialysis records; concurrent medications; comorbid conditions and surgeries; laboratory findings; imaging findings; and clinical outcome. A review of the dialysis and MR records between 2000 and 2006 showed 559 MRI examinations on 168 dialysis patients (including 301 contrast-enhanced examinations). RESULTS: NSF was diagnosed by clinical findings and tissue diagnosis. All 12 patients had renal insufficiency--eight with dialysis-dependent chronic renal insufficiency and four with acute hepatorenal syndrome. All 12 patients developed skin fibrosis within 2-11 weeks after gadodiamide administration. The odds ratio for development of NSF after gadodiamide exposure was 22.3. No other common event or exposure could be found. Four patients had abnormal scintigraphic bone scans with skin and muscle uptake and lower-extremity MRI finding of edema in the muscles, intermuscular fascia, and skin. Despite the fact that 10 patients were dialyzed within 2 days of gadodiamide administration, this did not prevent the development of NSF. CONCLUSION: Development of NSF was strongly associated with gadodiamide administration in the setting of either acute hepatorenal syndrome or dialysis-dependent chronic renal insufficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Grobner, T. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk062 · Cited by 1,859
Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M. B., Heaf, J. G., & Thomsen, H. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060601 · Cited by 1,400
Nephrotoxicity of high‐dose gadolinium compared with iodinated contrast
Prince, M. R., Arnoldus, C., & Frisoli, J. K. (1996) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880060129 · Cited by 398
What nephrologists need to know about gadolinium
Penfield, J. G., & Reilly, R. F. (2007) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0660 · Cited by 335
Collidge, T. A., Thomson, P. C., Mark, P. B., Traynor, J. P., Jardine, A. G., Morris, S. T. W., Simpson, K., & Roditi, G. H. (2007) · Radiology · doi:10.1148/radiol.2451070353 · Cited by 319
Dillman, J. R., Ellis, J. H., Cohan, R. H., Strouse, P. J., & Jan, S. C. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.07.2554 · Cited by 303
Ersoy, H., & Rybicki, F. J. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21135 · Cited by 283
Broome, D. R. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.02.011 · Cited by 283
Self-citationMolecular imaging with nanoparticles: giant roles for dwarf actors
Debbage, P., & Jaschke, W. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0511-y · Cited by 264
MR contrast agents: Physical and pharmacologic basics
Lin, S., & Brown, J. J. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20955 · Cited by 259
Rydahl, C., Thomsen, H. S., & Marckmann, P. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e31815a3407 · Cited by 252
Renal Cell Carcinoma: Diagnosis, Staging, and Surveillance
Ng, C. S., Wood, C. G., Silverman, P. M., Tannir, N. M., Tamboli, P., & Sandler, C. M. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.3568 · Cited by 242
MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis
Shellock, F. G., & Spinazzi, A. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.08.1038.1 · Cited by 221
Sieber, M. A., Lengsfeld, P., Frenzel, T., Golfier, S., Schmitt-Willich, H., Siegmund, F., Walter, J., Weinmann, H.-J., & Pietsch, H. (2008) · European Radiology · doi:10.1007/s00330-008-0977-y · Cited by 203
Cryptophane Xenon-129 Nuclear Magnetic Resonance Biosensors Targeting Human Carbonic Anhydrase
Chambers, J. M., Hill, P. A., Himmelberger, J. A., Han, Z., Christianson, D. W., Kuzma, N. N., & Dmochowski, I. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja806092w · Cited by 168
Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)
Galan, A., Cowper, S. E., & Bucala, R. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000245725.94887.8d · Cited by 163
Idée, J.-M., Port, M., Medina, C., Lancelot, E., Fayoux, E., Ballet, S., & Corot, C. (2008) · Toxicology · doi:10.1016/j.tox.2008.03.012 · Cited by 161
Edward, M., Quinn, J. A., Mukherjee, S., Jensen, M., Jardine, A. G., Mark, P. B., & Burden, A. D. (2008) · The Journal of Pathology · doi:10.1002/path.2311 · Cited by 129
Gibson, S. E., Farver, C. F., & Prayson, R. A. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-209-miinfd · Cited by 127
Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis
Swaminathan, S., High, W. A., Ranville, J. F., Horn, T. D., Hiatt, K. M., Thomas, M., Brown, H. H., & Shah, S. V. (2008) · Kidney International · doi:10.1038/ki.2008.76 · Cited by 104
What Nephrogenic Fibrosing Dermopathy Might Be
LeBoit, P. E. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.928 · Cited by 102
Editorial: Gadolinium Use in Patients with Kidney Disease: A Cause for Concern
Perazella, M. A., & Rodby, R. A. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00269.x · Cited by 92
Bhave, G. B., Lewis, J. B., & Chang, S. S. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.05.005 · Cited by 73
Gibbons, R. J., & Araoz, P. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.050 · Cited by 68
Penfield, J. G., & Reilly, R. F. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00408.x · Cited by 65
Grobner, T., & Prischl, F. C. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00406.x · Cited by 56
Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?
Bongartz, G. (2007) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-007-0071-5 · Cited by 51
Kranokpiraksa, P., & Kaufman, J. A. (2008) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2008.03.009 · Cited by 48
Nephrogenic systemic fibrosis: epidemiology update
Marckmann, P. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f4b605 · Cited by 44
Pedersen, M. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20983 · Cited by 41
The Impact of NSF on the Care of Patients With Kidney Disease
Abu‐Alfa, A. K. (2008) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2007.08.018 · Cited by 40
Magnetic Resonance Cardiac Vein Imaging
Chiribiri, A., Kelle, S., Köhler, U., et al. (2008) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.06.009 · Cited by 37
Anzalone, N., Scomazzoni, F., Cirillo, M., Cadioli, M., Iadanza, A., Kirchin, M. A., & Scotti, G. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e31817e9b0b · Cited by 36
Nephrogenic systemic fibrosis: An epidemic of gadolinium toxicity
Todd, D. J., & Kay, J. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0033-6 · Cited by 36
Nephrogenic Systemic Fibrosis and Gadolinium: A Perfect Storm
Colletti, P. M. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.08.1327 · Cited by 35
Nephrogenic systemic fibrosis and the role of gadolinium contrast media
van der Molen, A. J. (2008) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/j.1440-1673.2008.01965.x · Cited by 33
Nephrogenic system fibrosis: A radiologist's practical perspective
Martín, D. R. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.01.029 · Cited by 27
MR Angiography at 3 T for Assessment of the External Carotid Artery System
Lohan, D. G., Barkhordarian, F., Saleh, R. S., Krishnam, M. S., Salamon, N., Ruehm, S. G., & Finn, J. P. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.07.2235 · Cited by 27
Dawson, P., & Punwani, S. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00401.x · Cited by 25
Reichardt, W., Romaker, D., Becker, A., Büchert, M., Walz, G., & von Elverfeldt, D. (2008) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-008-0158-7 · Cited by 25
Balci, N. C., Befeler, A. S., Leiva, P., Pilgram, T. K., & Havlioglu, N. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05434.x · Cited by 23
Whole-body magnetic resonance angiography at 3.0 Tesla
Fenchel, M. C., Nael, K., Seeger, A., Krämer, U., Saleh, R. S., & Miller, S. (2008) · European Radiology · doi:10.1007/s00330-008-0885-1 · Cited by 13
Progressive arm and leg stiffness in a patient with chronic renal impairment
Shin, K., Granter, S. R., Coblyn, J. S., & Gupta, S. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0883 · Cited by 11
Leyendecker, J. R., & Childs, D. D. (2007) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2007.06.007 · Cited by 10
Willicombe, M. K., & Cunningham, J. A. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00400.x · Cited by 8
Forman, H. P. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1635 · Cited by 5
Long-term control of macroprolactinomas
Bronstein, M. D. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.3.361 · Cited by 1
Cited by
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
Della Rocca, J., Liu, D., & Lin, W. (2011) · Accounts of Chemical Research · doi:10.1021/ar200028a · Cited by 2,087
ACR Guidance Document for Safe MR Practices: 2007
Kanal, E., Barkovich, A. J., Bell, C., Borgstede, J. P., Bradley, W. G., Froelich, J. W., Gilk, T., Gimbel, J. R., Gosbee, J., Kuhni-Kaminski, E., et al. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1616 · Cited by 787
Guidelines for Acromegaly Management: An Update
Melmed, S., Colao, A., Barkan, A., Molitch, M., Grossman, A. B., Kleinberg, D., Clemmons, D., Chanson, P., Laws, E., Schlechte, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2421 · Cited by 764
Dai, C., Chen, Y., Jing, X., Xiang, L., Yang, D., Lin, H., Liu, Z., Han, X., & Wu, R. (2017) · ACS Nano · doi:10.1021/acsnano.7b07241 · Cited by 520
Emerging applications for ferumoxytol as a contrast agent in MRI
Bashir, M. R., Bhatti, L., Marin, D., & Nelson, R. C. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24691 · Cited by 371
Metadata
- Authors
- Broome, D. R., Girguis, M. S., Baron, P. W., Cottrell, A. C., Kjellin, I., & Kirk, G. A.
- Venue
- American Journal of Roentgenology
- Publisher
- American Roentgen Ray Society
- Published
- 2007-02
- Volume
- 188
- Issue
- 2
- Pages
- 586-592
- ISSN
- 0002-9580 (ISSN-L)
- 0361-803X
- 1546-3141
- OpenAlex
- W2010191338
- Cited by
- 604
- References
- 48
- FWCI
- 64.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.